Followers | 3345 |
Posts | 84506 |
Boards Moderated | 7 |
Alias Born | 10/05/2005 |
Monday, April 08, 2019 9:27:26 AM
Date : 04/04/2019 @ 9:00AM
Source : PR Newswire (US)
Stock : Shineco, Inc. (TYHT)
Quote : 1.48 0.0 (0.00%) @ 9:11AM
Shineco, Inc. Enters into Strategic Cooperation Agreement with Regional People's Government for Construction of Industrial He...
Alert
Shineco, Inc. (NASDAQ:TYHT)
Historical Stock Chart
1 Month : From Mar 2019 to Apr 2019
Click Here for more Shineco, Inc. Charts.
BEIJING, April 4, 2019 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that the Company, through its wholly owned subsidiary Tenjove NewHemp Biotech Co., Ltd. ("TNB"), entered into a strategic cooperation agreement (the "Agreement") with the Xingshan People's Government of Hegang City of Heilongjiang Province (the "Government").
Pursuant to the Agreement, both parties agree to actively promote the development of a complete industrial chain for industrial hemp including cultivation, harvesting, initial processing and fine extraction to form a local industry integration model and to achieve a new industrial scale economy.
As part of the Agreement, both parties plan to develop a 20,000 mu (approximately 3,295 acres) high-quality industrial hemp project and expect to complete the cultivation of the first 500 mu in 2019. Besides conducting joint research and development on several new varieties of industrial hemp, both parties also agree to establish an industrial hemp farm, a CBD Extraction Industrial Park, an Industrial Hemp Research Center affiliated with the China's Academy of Science, and an Industrial Hemp Workstation sponsored by the City of Hegang of Heilongjiang Province.
Mr. Yuying Zhang, Chairman and Chief Executive Officer of Shineco, commented, "we are pleased to announce this agreement with the Xingshan People's Government of Hegang City. We expect an annual production of 30 tons of CBD extract, and other raw medical materials from our industrial hemp project, along with 2,000 tons of industrial hemp fiber, 500 tons of industrial hemp seed oil and 4,000 tons of hemp leaves. We estimate the value of the CBD and related raw medical extract alone to reach RMB2.1 billion, given the robust demand for CBD products and the resulting high market price. We look forward to leveraging our extensive experience in processing and marketing agricultural products and sharing our expertise with the appropriate authorities to ensure a profitable, environmentally friendly, and socially conscious development path in line with local government expectations."
About Shineco, Inc.
Incorporated in Delaware in August 1997 and headquartered in Beijing, China, Shineco, Inc. ("Shineco" or the "Company") is a holding company, through its subsidiaries and variable interest entities, undertakes vertically- and horizontally-integrated production, distribution and sales channels to provide health and well-being focused plant-based products in China. Utilizing modern engineering technologies and biotechnologies, Shineco produces, among other products, Chinese herbal medicines, organic agricultural produce and specialized textiles. For more information about the Company, please visit www.tenetjove.com.
Forward-Looking Statements
This press release contains information about Shineco's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. Shineco encourages you to review other factors that may affect its future results in Shineco's registration statement and in its other filings with the Securities and Exchange Commission.
For more information, please contact:
Tina Xiao
Ascent Investor Relations LLC
Phone: +1-917-609-0333
Email: tina.xiao@ascent-ir.com
Cision View original content:http://www.prnewswire.com/news-releases/shineco-inc-enters-into-strategic-cooperation-agreement-with-regional-peoples-government-for-construction-of-industrial-hemp-planting-base-300824643.html
SOURCE Shineco, Inc
Copyright 2019 PR Newswire
Lets exchange member marks and exchange market moving information today!
All my posts are strictly my opinion only! Please do your own DD.
Recent SISI News
- Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry • PR Newswire (US) • 05/01/2024 09:14:00 AM
- Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 03/12/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:10:36 PM
- Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement • GlobeNewswire Inc. • 02/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/08/2024 09:16:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:10:21 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/16/2024 05:05:05 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/05/2024 10:29:35 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/04/2024 09:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:30:18 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/26/2023 09:45:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:10:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:10:17 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/01/2023 02:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:10:34 PM
- Shineco Announces the Appointment of Two New Executive Officers • GlobeNewswire Inc. • 11/17/2023 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:31:01 PM
- Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition • GlobeNewswire Inc. • 10/30/2023 01:00:00 PM
- Shineco to Increase R&D to Explore New High-Tech Medical Product Applications • GlobeNewswire Inc. • 10/04/2023 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/29/2023 08:16:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 08:16:10 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 08/29/2023 05:26:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 08:45:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM